Pw. Szlosarek et al., Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel, ANTI-CANC D, 11(4), 2000, pp. 275-278
The rarity of endometrial stromal sarcoma (ESS) and its poor response to tr
eatment provides fertile ground for investigational therapies. An accelerat
ed regimen of carboplatin and paclitaxel is investigated. A patient with a
recent history of treated tuberculosis of the lung represented with inferti
lity and acute abdominal pain from suspected fibroids, and underwent a lapa
rotomy with a diagnosis of a high-grade ESS. A novel therapeutic approach u
sing a regimen of carboplatin and paclitaxel with the reinfusion of filgras
tim-mobilized peripheral blood progenitor cells is described. A partial res
ponse was observed following six cycles of chemotherapy. Grade IV thrombocy
topenia occurred after the last cycle, with recovery prior to pelvic radiot
herapy. The patient remained well 1 year post-diagnosis. High-grade ESS is
responsive to combination chemotherapy with paclitaxel and carboplatin, and
requires further evaluation. The use of an accelerated regimen may also ha
ve contributed to the response and this question awaits randomized trials.
[(C) 2000 Lippincott Williams & Wilkins.].